Is SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 15 September 1992; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

What is the revenue of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE?

As a small company, SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -6,142.

SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE

Q: What is the address of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE?

The registered office of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE is located at Place des Guillemins 2, 4000 Liège.

Q: Is SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE still active?

Not as usual. The CBE lists SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE with legal situation “Vrijwillige ontbinding – vereffening”.

Q: Is SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE registered on Peppol?

No, SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE is currently not registered on the Peppol network.

Q: What is the enterprise number of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE?

The enterprise number of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE is BE0448405957.

Q: Who are the directors of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE?

According to the 2025 annual accounts, the directors of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE are: SPRL Laurent STAS de RICHELLE.

Dossier SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE, printed on 31 October 2026 from databakkes.be/en/0448405957/societe-universitaire-de-promotion-de-la-recherche-medicale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2025

SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE from Liège, company number BE0448405957, closed financial year 2025 with a result of € -16,835 after tax. For that financial year SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE recorded a gross margin of € -6,142 and equity of € 12,701. Compared with financial year 2024, the result moved from € -99,566 to € -16,835. The company made a loss. The buffer shrank hard: equity is 57 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 6, 2026.

What it is worth Shrank hard

€ 12,701

▼ 57% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -16,835

▲ 83 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,866

▼ 60% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 10.8 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 270

▼ 92% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -11,632 Gross margin 2022: € -11,632 First fiscal year in the series	€ -13,676 Gross margin 2023: € -13,676 ▼ € 2,044 vs 2022 (€ -11,632) Unfavourable step	€ -99,566 Gross margin 2024: € -99,566 ▼ € 85,890 vs 2023 (€ -13,676) Unfavourable step	€ -6,142 Gross margin 2025: € -6,142 ▲ € 93,424 vs 2024 (€ -99,566) Favourable step	▲ € 93,424
Profit after taxes	€ -21,083 Profit after taxes 2022: € -21,083 First fiscal year in the series	€ -16,200 Profit after taxes 2023: € -16,200 ▲ € 4,883 vs 2022 (€ -21,083) Favourable step	€ -99,566 Profit after taxes 2024: € -99,566 ▼ € 83,366 vs 2023 (€ -16,200) Unfavourable step	€ -16,835 Profit after taxes 2025: € -16,835 ▲ € 82,731 vs 2024 (€ -99,566) Favourable step	▲ € 82,731
Equity	€ 2,851,993 Equity 2022: € 2,851,993 First fiscal year in the series	€ 2,835,793 Equity 2023: € 2,835,793 ▼ 1% vs 2022 (€ 2,851,993) Unfavourable step	€ 29,536 Equity 2024: € 29,536 ▼ 99% vs 2023 (€ 2,835,793) Unfavourable step	€ 12,701 Equity 2025: € 12,701 ▼ 57% vs 2024 (€ 29,536) Unfavourable step	▼ 57%
Total debts	€ 9,357 Total debts 2022: € 9,357 First fiscal year in the series	€ 1,556 Total debts 2023: € 1,556 ▼ 83% vs 2022 (€ 9,357) Favourable step	€ 3,308 Total debts 2024: € 3,308 ▲ 113% vs 2023 (€ 1,556) Unfavourable step	€ 270 Total debts 2025: € 270 ▼ 92% vs 2024 (€ 3,308) Favourable step	▼ 92%
Cash	€ 2,606,961 Cash 2022: € 2,606,961 First fiscal year in the series	€ 2,837,180 Cash 2023: € 2,837,180 ▲ 9% vs 2022 (€ 2,606,961) Favourable step	€ 32,304 Cash 2024: € 32,304 ▼ 99% vs 2023 (€ 2,837,180) Unfavourable step	€ 12,866 Cash 2025: € 12,866 ▼ 60% vs 2024 (€ 32,304) Unfavourable step	▼ 60%
Land & buildings	€ 9,401 Land & buildings 2022: € 9,401 First fiscal year in the series	-	-	-
Retained profit	€ 10,891,993 Retained profit 2022: € 10,891,993 First fiscal year in the series	€ 10,875,793 Retained profit 2023: € 10,875,793 Unchanged (€ 10,891,993) Unfavourable step	€ 10,776,227 Retained profit 2024: € 10,776,227 ▼ 1% vs 2023 (€ 10,875,793) Unfavourable step	€ 10,759,392 Retained profit 2025: € 10,759,392 Unchanged (€ 10,776,227) Unfavourable step
Balance sheet total	€ 2,861,350 Balance sheet total 2022: € 2,861,350 First fiscal year in the series	€ 2,837,349 Balance sheet total 2023: € 2,837,349 ▼ 1% vs 2022 (€ 2,861,350) Unchanged	€ 32,844 Balance sheet total 2024: € 32,844 ▼ 99% vs 2023 (€ 2,837,349) Unchanged	€ 12,971 Balance sheet total 2025: € 12,971 ▼ 61% vs 2024 (€ 32,844) Unchanged	▼ 61%

Key figures of SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE?

What happened at SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

Mar 6, 2026 New annual accounts for financial year 2025: loss of € 16,835. Source: NBB ↗
2015 SPRL Laurent STAS de RICHELLE became a director. NBB
Dec 11, 1992 New establishment in Liège. KBO
Sep 15, 1992 Start of the company according to the CBE. KBO

In short

From € 21,083 loss in 2022 to € 16,835 loss in 2025.

Paid € 55,760 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

Management

SPRL Laurent STAS de RICHELLE

SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE

LF AVOCATS

VISE CONSTRUCTIONS

Behind SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE is SPRL Laurent STAS de RICHELLE. SPRL Laurent STAS de RICHELLE is also behind LF AVOCATS and VISE CONSTRUCTIONS.

Directors

According to the 2025 annual accounts

SPRL Laurent STAS de RICHELLE

Liquidator

Also active at: LF AVOCATS, VISE CONSTRUCTIONS

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Place des Guillemins 2

4000 Liège

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

AMICALE DES CONDUCTEURS DE LIEGE ET HUY

proWIN Belgium

€ 85,419 gross margin · 2025

FABREUIL INVESTISSEMENT

€ -12,999 gross margin · 2025

SHENGDA

Ecran Total International

€ 22,733 gross margin · 2025

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0448.405.957

VAT number

BE 0448.405.957

Registered office

Place des Guillemins 2, 4000 Liège

Names & denominations

SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE · S.U.P.R.E.M.E.

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Vrijwillige ontbinding – vereffening

Start date

15 September 1992

Peppol

Not registered

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige ondersteunende activiteiten in verband met financiële diensten, neg, exclusief verzekeringen en pensioenfondsen

View on CBE Public ↗ Annual accounts (NBB) ↗

SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE

Warning lights

Financials

What happened to SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions